Neuroone®宣布签署一项新的南加州分销协议，旨在进一步推进其已获FDA批准的Onerf®三叉神经消融系统在美商业化布局。
这项合作将有力拓展该创新医疗设备在美国市场的覆盖范围，标志着公司在商业化推进进程中再落关键一子。通过携手南加州分销伙伴，Neuroone®正加大力度触达更多医疗终端，为患者提供针对三叉神经痛的精准治疗选择。
Onerf®系统作为一款经FDA审批的先进医疗设备，其临床价值与应用前景正逐步赢得市场认可。此番分销协议的落地，无疑为该系统在美国南部地区的推广注入了新的动力，也折射出公司深耕神经调控领域的战略定力与执行力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.